Olivera Story Jovanova,Ivana Nedeljkovic,Derek Spieler,Rosie M Walker,Chunyu Liu,Michelle Luciano,Jan Bressler,Jennifer Brody,Amanda J Drake,Kathryn L Evans,Rahul Gondalia,Sonja Kunze,Brigitte Kuhnel,Jari Lahti,Rozenn N Lemaitre,Riccardo E Marioni,Brenton Swenson,Jayandra Jung Himali,Hongsheng Wu,Yun Li,Allan F McRae,Tom C Russ,James Stewart,Zhiying Wang,Guosheng Zhang,Karl-Heinz Ladwig,Andre G Uitterlinden,Xiuqing Guo,Annette Peters,Katri Räikkönen,John M Starr,Melanie Waldenberger,Naomi R Wray,Eric A Whitsel,Nona Sotoodehnia,Sudha Seshadri,David J Porteous,Joyce van Meurs,Thomas H Mosley,Andrew M McIntosh,Michael M Mendelson,Daniel Levy,Lifang Hou,Johan G Eriksson,Myriam Fornage,Ian J Deary,Andrea Baccarelli,Henning Tiemeier,Najaf Amin

Abstract:Importance: Depressive disorders arise from a combination of genetic and environmental risk factors. Epigenetic disruption provides a plausible mechanism through which gene-environment interactions lead to depression. Large-scale, epigenome-wide studies on depression are missing, hampering the identification of potentially modifiable biomarkers. Objective: To identify epigenetic mechanisms underlying depression in middle-aged and elderly persons, using DNA methylation in blood. Design, setting, and participants: To date, the first cross-ethnic meta-analysis of epigenome-wide association studies (EWAS) within the framework of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium was conducted. The discovery EWAS included 7948 individuals of European origin from 9 population-based cohorts. Participants who were assessed for both depressive symptoms and whole-blood DNA methylation were included in the study. Results of EWAS were pooled using sample-size weighted meta-analysis. Replication of the top epigenetic sites was performed in 3308 individuals of African American and European origin from 2 population-based cohorts. Main outcomes and measures: Whole-blood DNA methylation levels were assayed with Illumina-Infinium Human Methylation 450K BeadChip and depressive symptoms were assessed by questionnaire. Results: The discovery cohorts consisted of 7948 individuals (4104 [51.6%] women) with a mean (SD) age of 65.4 (5.8) years. The replication cohort consisted of 3308 individuals (2456 [74.2%] women) with a mean (SD) age of 60.3 (6.4) years. The EWAS identified methylation of 3 CpG sites to be significantly associated with increased depressive symptoms: cg04987734 (P = 1.57 × 10-08; n = 11 256; CDC42BPB gene), cg12325605 (P = 5.24 × 10-09; n = 11 256; ARHGEF3 gene), and an intergenic CpG site cg14023999 (P = 5.99 × 10-08; n = 11 256; chromosome = 15q26.1). The predicted expression of the CDC42BPB gene in the brain (basal ganglia) (effect, 0.14; P = 2.7 × 10-03) and of ARHGEF3 in fibroblasts (effect, -0.48; P = 9.8 × 10-04) was associated with major depression. Conclusions and relevance: This study identifies 3 methylated sites associated with depressive symptoms. All 3 findings point toward axon guidance as the common disrupted pathway in depression. The findings provide new insights into the molecular mechanisms underlying the complex pathophysiology of depression. Further research is warranted to determine the utility of these findings as biomarkers of depression and evaluate any potential role in the pathophysiology of depression and their downstream clinical effects.

Genome-wide profiling of DNA methylome and transcriptome in peripheral blood monocytes for major depression: A Monozygotic Discordant Twin Study

Genome-wide DNA methylation and gene expression analyses in monozygotic twins identify potential biomarkers of depression

Integrated Analysis of Methylomic and Transcriptomic Data to Identify Potential Diagnostic Biomarkers for Major Depressive Disorder

Microarray Analysis of the Major Depressive Disorder Mrna Profile Data.

Gene Expression Profiling in Peripheral Blood Lymphocytes for Major Depression: Preliminary Cues from Chinese Discordant Sib-Pair Study

Genome-wide DNA methylation analysis of discordant monozygotic twins reveals consistent sites of differential methylation associated with congenital heart disease

Integrative omics analysis reveals epigenomic and transcriptomic signatures underlying brain structural deficits in major depressive disorder

Investigating the Epigenetic Landscape of Major Depressive Disorder: A Genome-Wide Meta-Analysis of DNA Methylation Data, Including New Insights into Stochastic Epigenetic Mutations and Epivariations

Childhood Trauma, DNA Methylation of Stress-Related Genes, and Depression: Findings From Two Monozygotic Twin Studies

Convergence of Evidence from a Methylome-Wide CpG-SNP Association Study and GWAS of Major Depressive Disorder

A Joint Study of Whole Exome Sequencing and Structural MRI Analysis in Major Depressive Disorder.

Multi-Omics Integration Reveals Transcriptomic and Epigenetic Signatures Underlying Brain Structural Deficits in Major Depressive Disorder

Epigenome-Wide DNA Methylation in Unipolar Depression: Predictive Biomarker of Antidepressant Treatment Response?

DNA Methylation Signatures of Depressive Symptoms in Middle-aged and Elderly Persons: Meta-analysis of Multiethnic Epigenome-wide Studies

Abstract P264: DNA Methylation and Differences in Blood Pressure Levels in Monozygotic Twins

Serotonin transporter promoter methylation in peripheral cells and neural responses to negative stimuli: A study of adolescent monozygotic twins

Peripheral Blood Mononuclear Cell Biomarkers for Major Depressive Disorder: A Transcriptomic Approach

Neuroimaging and epigenetic analysis reveal novel epigenetic loci in major depressive disorder

Genome-wide methylome-based molecular pathologies associated with depression and suicide

Decoding depression: a comprehensive multi-cohort exploration of blood DNA methylation using machine learning and deep learning approaches

DNA methylation in depression and depressive-like phenotype: biomarker or target of pharmacological intervention?